INS and polycystic ovary syndrome: The purpose of this study was therefore to investigate the effectiveness of 3 mg DRSP/20 μg EE in treating PCOS patients in terms of cardiometabolic risk factors, sex hormone related variation and lipid parameters including fasting blood glucose and insulin levels.